Context Therapeutics
CNTX
CNTX
39 hedge funds and large institutions have $45M invested in Context Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-3
Holders Change %
-7.14%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
8
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
LM
Luminus Management
Houston,
Texas
|
+$215K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$70.2K |
| 3 |
MCCA
Mill Creek Capital Advisors
Conshohocken,
Pennsylvania
|
+$68.6K |
| 4 |
GS
GTS Securities
New York
|
+$28.9K |
| 5 |
BOCH
Blue Owl Capital Holdings
New York
|
+$26.2K |
Top Sellers
| 1 |
ABG
Ally Bridge Group
New York
|
-$708K |
| 2 |
AI
Allostery Investments
Stamford,
Connecticut
|
-$582K |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$446K |
| 4 |
SC
Shay Capital
New York
|
-$116K |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$93.4K |
